These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 6611419

  • 1. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G, Bause I, Kneba M, Kehl A, Nagel GA.
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [Abstract] [Full Text] [Related]

  • 2. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W, Amlot PL, Williams BD.
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [Abstract] [Full Text] [Related]

  • 3. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L, Glikmann G, Jensenius JC, Svehag SE.
    J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
    [Abstract] [Full Text] [Related]

  • 4. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR, Miltenburg AM, Hiemstra PS, Klar-Mohamad N, Van Es LA, Van Hinsbergh VW.
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [Abstract] [Full Text] [Related]

  • 5. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA, Walker LC, Steere AC, Trumble TC, Tung KS, Williams RC, Ruddy S, Malawista SE.
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [Abstract] [Full Text] [Related]

  • 6. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
    Soltis RD, Hasz DE.
    J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
    [Abstract] [Full Text] [Related]

  • 7. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME.
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [Abstract] [Full Text] [Related]

  • 8. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G, Kneba M, Bolz I, Volling P, Wessels J, Nagel GA.
    J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
    [Abstract] [Full Text] [Related]

  • 9. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM, Moore M, Hilton AM.
    Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
    [Abstract] [Full Text] [Related]

  • 10. Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.
    Rossen RD, Zubler RH, Day NK, Reisberg MA, Morgan AC, Gutterman JU, Hersh EM.
    J Lab Clin Med; 1978 Feb; 91(2):191-204. PubMed ID: 413872
    [Abstract] [Full Text] [Related]

  • 11. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G, Bloemmen FJ, Ceuppens JL, Stevens EA.
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [Abstract] [Full Text] [Related]

  • 12. Reactivity of low molecular weight material in cellular immune complex assays.
    Cooper KM, Moore M.
    Clin Exp Immunol; 1983 May; 52(2):407-16. PubMed ID: 6602679
    [Abstract] [Full Text] [Related]

  • 13. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
    Caillot G, Lamelin JP, Hartmann DJ, Ville G.
    Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
    Poulton TA, Mooney NA, Nineham LJ, Hay FC.
    Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
    [Abstract] [Full Text] [Related]

  • 15. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W, Hiepe F, Courault K, Porstmann B, Apostoloff E.
    Biomed Biochim Acta; 1983 Sep; 42(7-8):1027-35. PubMed ID: 6360166
    [Abstract] [Full Text] [Related]

  • 16. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
    Veerhuis R, van Es LA, Daha MR.
    Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
    [Abstract] [Full Text] [Related]

  • 17. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
    Belozerov AP.
    Lab Delo; 1989 Apr; (3):24-6. PubMed ID: 2469833
    [Abstract] [Full Text] [Related]

  • 18. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E, Sorvillo J, Gigli I.
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [Abstract] [Full Text] [Related]

  • 19. [Immune complexes in the serum of patients with acute myeloblastic leukemia].
    Späth P, Berchtold P, Engler H, Bütler R.
    Schweiz Med Wochenschr; 1984 Oct 06; 114(40):1373-5. PubMed ID: 6593823
    [Abstract] [Full Text] [Related]

  • 20. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
    Rossen RD, Crane MM, Morgan AC, Giannini EH, Giovanella BC, Stehlin JS, Twomey JJ, Hersh EM.
    Cancer Res; 1983 Jan 06; 43(1):422-9. PubMed ID: 6600161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.